

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.37181494 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.34200003 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.27628233 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.23034563 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.72459520 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60997192 |
| 7 | glutamate secretion (GO:0014047) | 4.57435928 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.45143615 |
| 9 | vocalization behavior (GO:0071625) | 4.22439064 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.20635700 |
| 11 | regulation of synaptic vesicle transport (GO:1902803) | 4.15644953 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.14014210 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.00822025 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.99734768 |
| 15 | exploration behavior (GO:0035640) | 3.94067057 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.90680710 |
| 17 | cellular potassium ion homeostasis (GO:0030007) | 3.90046289 |
| 18 | neurotransmitter secretion (GO:0007269) | 3.88061752 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.87299504 |
| 20 | layer formation in cerebral cortex (GO:0021819) | 3.86029669 |
| 21 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.74946901 |
| 22 | protein localization to synapse (GO:0035418) | 3.74514088 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.74365689 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 3.67656936 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 3.64106598 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62538893 |
| 27 | cell communication by electrical coupling (GO:0010644) | 3.60689039 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54927563 |
| 29 | sodium ion export (GO:0071436) | 3.54403616 |
| 30 | glycerophospholipid catabolic process (GO:0046475) | 3.51190656 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.50842041 |
| 32 | synaptic transmission, glutamatergic (GO:0035249) | 3.48545946 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.47405185 |
| 34 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.45222618 |
| 35 | activation of protein kinase A activity (GO:0034199) | 3.43869300 |
| 36 | positive regulation of neurotransmitter transport (GO:0051590) | 3.41832374 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.41015514 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.40968524 |
| 39 | proline transport (GO:0015824) | 3.40638183 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.39973154 |
| 41 | long-term memory (GO:0007616) | 3.39769676 |
| 42 | long-term synaptic potentiation (GO:0060291) | 3.37425335 |
| 43 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.36451735 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.30719635 |
| 45 | regulation of vesicle fusion (GO:0031338) | 3.30118985 |
| 46 | response to dietary excess (GO:0002021) | 3.29419741 |
| 47 | response to auditory stimulus (GO:0010996) | 3.27418805 |
| 48 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.26239932 |
| 49 | detection of calcium ion (GO:0005513) | 3.26045134 |
| 50 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.25525416 |
| 51 | innervation (GO:0060384) | 3.23909909 |
| 52 | neuron-neuron synaptic transmission (GO:0007270) | 3.22174679 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.20111983 |
| 54 | neurotransmitter transport (GO:0006836) | 3.17711079 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.13773161 |
| 56 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.13613399 |
| 57 | positive regulation of membrane potential (GO:0045838) | 3.11923388 |
| 58 | positive regulation of vesicle fusion (GO:0031340) | 3.10763855 |
| 59 | presynaptic membrane assembly (GO:0097105) | 3.10712943 |
| 60 | presynaptic membrane organization (GO:0097090) | 3.09819224 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.09002905 |
| 62 | astrocyte differentiation (GO:0048708) | 3.08246870 |
| 63 | endocrine pancreas development (GO:0031018) | 3.07564216 |
| 64 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.05693117 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.05435242 |
| 66 | regulation of neurotransmitter secretion (GO:0046928) | 3.03072199 |
| 67 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02612024 |
| 68 | chemosensory behavior (GO:0007635) | 3.02042283 |
| 69 | regulation of beta-amyloid formation (GO:1902003) | 3.01753533 |
| 70 | positive regulation of insulin secretion (GO:0032024) | 3.01329372 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.00626431 |
| 72 | membrane repolarization (GO:0086009) | 2.99131665 |
| 73 | epithelial cell fate commitment (GO:0072148) | 2.97643208 |
| 74 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.97171625 |
| 75 | cerebellar Purkinje cell layer development (GO:0021680) | 2.97091117 |
| 76 | auditory behavior (GO:0031223) | 2.96442455 |
| 77 | neuron recognition (GO:0008038) | 2.96435425 |
| 78 | glycine transport (GO:0015816) | 2.96225456 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.95218428 |
| 80 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.94087873 |
| 81 | artery smooth muscle contraction (GO:0014824) | 2.92990621 |
| 82 | regulation of neurotransmitter uptake (GO:0051580) | 2.92891714 |
| 83 | potassium ion import (GO:0010107) | 2.92512350 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92392162 |
| 85 | regulation of neurotransmitter levels (GO:0001505) | 2.91764166 |
| 86 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90812283 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 2.90754937 |
| 88 | axon ensheathment in central nervous system (GO:0032291) | 2.89722950 |
| 89 | central nervous system myelination (GO:0022010) | 2.89722950 |
| 90 | peptide hormone secretion (GO:0030072) | 2.89648777 |
| 91 | dendritic spine organization (GO:0097061) | 2.87456317 |
| 92 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.85214628 |
| 93 | nitric oxide mediated signal transduction (GO:0007263) | 2.83934653 |
| 94 | inositol phosphate catabolic process (GO:0071545) | 2.82840434 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.82162509 |
| 96 | negative regulation of hormone metabolic process (GO:0032351) | 2.81826774 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 2.81428235 |
| 98 | regulation of neurotransmitter transport (GO:0051588) | 2.81142978 |
| 99 | peptide secretion (GO:0002790) | 2.80992081 |
| 100 | membrane repolarization during action potential (GO:0086011) | 2.80227867 |
| 101 | insulin secretion (GO:0030073) | 2.78063112 |
| 102 | potassium ion homeostasis (GO:0055075) | 2.77325665 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 2.76819690 |
| 104 | macroautophagy (GO:0016236) | 2.75599576 |
| 105 | neuronal ion channel clustering (GO:0045161) | 2.75528892 |
| 106 | alanine transport (GO:0032328) | 2.75407215 |
| 107 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.75304502 |
| 108 | cellular ketone body metabolic process (GO:0046950) | 2.75225828 |
| 109 | Golgi transport vesicle coating (GO:0048200) | 2.75014080 |
| 110 | COPI coating of Golgi vesicle (GO:0048205) | 2.75014080 |
| 111 | positive regulation of potassium ion transport (GO:0043268) | 2.74958695 |
| 112 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.74275113 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.73519812 |
| 114 | axonal fasciculation (GO:0007413) | 2.72799680 |
| 115 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.72574075 |
| 116 | postsynaptic membrane organization (GO:0001941) | 2.72390087 |
| 117 | dendrite morphogenesis (GO:0048813) | 2.72240147 |
| 118 | regulation of insulin secretion (GO:0050796) | 2.71664318 |
| 119 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.71374271 |
| 120 | L-amino acid import (GO:0043092) | 2.70505225 |
| 121 | positive regulation of synapse maturation (GO:0090129) | 2.69017691 |
| 122 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.68055552 |
| 123 | positive regulation of peptide hormone secretion (GO:0090277) | 2.67985474 |
| 124 | membrane depolarization during action potential (GO:0086010) | 2.66745273 |
| 125 | cellular sodium ion homeostasis (GO:0006883) | 2.66674871 |
| 126 | positive regulation of peptide secretion (GO:0002793) | 2.65891761 |
| 127 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65685535 |
| 128 | regulation of synaptic transmission (GO:0050804) | 2.65073001 |
| 129 | signal release (GO:0023061) | 2.61789419 |
| 130 | negative regulation of dendrite development (GO:2000171) | 2.59232364 |
| 131 | cerebellar granule cell differentiation (GO:0021707) | 2.57260917 |
| 132 | glandular epithelial cell differentiation (GO:0002067) | 2.57024546 |
| 133 | positive regulation of glycolytic process (GO:0045821) | 2.56420012 |
| 134 | startle response (GO:0001964) | 2.54557053 |
| 135 | neurotransmitter uptake (GO:0001504) | 2.52424067 |
| 136 | inositol phosphate dephosphorylation (GO:0046855) | 2.51979988 |
| 137 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.51979988 |
| 138 | response to gravity (GO:0009629) | 2.50798781 |
| 139 | tonic smooth muscle contraction (GO:0014820) | 2.48025006 |
| 140 | regulation of hexokinase activity (GO:1903299) | 2.47848977 |
| 141 | regulation of glucokinase activity (GO:0033131) | 2.47848977 |
| 142 | type B pancreatic cell development (GO:0003323) | 2.47342757 |
| 143 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.46972016 |
| 144 | regulation of peptide hormone secretion (GO:0090276) | 2.46365264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.64717498 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.52781006 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05213943 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04795973 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96969207 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84992813 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.76963193 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59348359 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.58115820 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55664093 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54867172 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54867172 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54786803 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.54273688 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50785833 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50608146 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43362655 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40265878 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25047593 |
| 20 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.24694126 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20847318 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20682667 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16480873 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.05013647 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99534824 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74358133 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73157352 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72101513 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69715171 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.61230090 |
| 31 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60016820 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55516266 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55436117 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48255124 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47072764 |
| 36 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46114580 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42616084 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38535167 |
| 39 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.35765102 |
| 40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34712310 |
| 41 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31880250 |
| 42 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31681249 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30721370 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30083596 |
| 45 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28824157 |
| 46 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28529689 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26562733 |
| 48 | AR_19668381_ChIP-Seq_PC3_Human | 1.25345657 |
| 49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24575425 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24220373 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24106616 |
| 52 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24057542 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23616301 |
| 54 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22986874 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22525043 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22327178 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22006358 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21159419 |
| 59 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19130031 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18870203 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18530526 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18305279 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16333197 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16035738 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15875439 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14929614 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14792532 |
| 68 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14292870 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14167138 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13822719 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13334212 |
| 72 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12760695 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12677270 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12497804 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10721146 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09316015 |
| 77 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06712542 |
| 78 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06285515 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05968498 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05106317 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04976444 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04752259 |
| 83 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04523576 |
| 84 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04440389 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04113589 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02425872 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02190154 |
| 88 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01811956 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01618480 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01569601 |
| 91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01094172 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99520375 |
| 93 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99255169 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98398230 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98188294 |
| 96 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97985990 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97136964 |
| 98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96916870 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96557511 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95982878 |
| 101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95944683 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95290122 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94411975 |
| 104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94210746 |
| 105 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94099142 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93922800 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93736955 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93574444 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93414247 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93370788 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93272064 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92868918 |
| 113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92658024 |
| 114 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92279703 |
| 115 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92244876 |
| 116 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91502654 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89135639 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88763689 |
| 119 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87493145 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85094369 |
| 121 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84217945 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84113018 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83784523 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83655336 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83237455 |
| 126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82319539 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.82191041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.74514819 |
| 2 | MP0003880_abnormal_central_pattern | 3.88282118 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.69160403 |
| 4 | MP0004270_analgesia | 3.65105101 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.36388160 |
| 6 | MP0002909_abnormal_adrenal_gland | 3.15528196 |
| 7 | MP0002063_abnormal_learning/memory/cond | 2.96905066 |
| 8 | MP0009745_abnormal_behavioral_response | 2.91174478 |
| 9 | MP0002064_seizures | 2.71261876 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.51724027 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.42621413 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.37872558 |
| 13 | MP0009046_muscle_twitch | 2.29287890 |
| 14 | MP0004858_abnormal_nervous_system | 2.27504970 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.27096057 |
| 16 | MP0002272_abnormal_nervous_system | 2.24816856 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.23936351 |
| 18 | MP0001486_abnormal_startle_reflex | 2.23326051 |
| 19 | MP0003283_abnormal_digestive_organ | 2.22079773 |
| 20 | * MP0002734_abnormal_mechanical_nocicepti | 2.18793798 |
| 21 | MP0002822_catalepsy | 2.10795766 |
| 22 | MP0003123_paternal_imprinting | 2.08238281 |
| 23 | MP0003329_amyloid_beta_deposits | 2.07152007 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.01019163 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.95704964 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.89762039 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.80597389 |
| 28 | MP0002736_abnormal_nociception_after | 1.73344440 |
| 29 | MP0008569_lethality_at_weaning | 1.73215768 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.70119136 |
| 31 | MP0004043_abnormal_pH_regulation | 1.69234136 |
| 32 | * MP0001970_abnormal_pain_threshold | 1.69053253 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.68130488 |
| 34 | MP0004885_abnormal_endolymph | 1.66942367 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.64479288 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.63299708 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.61575265 |
| 38 | MP0002163_abnormal_gland_morphology | 1.60728343 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.60427905 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.59333554 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.57337474 |
| 42 | MP0003121_genomic_imprinting | 1.56024195 |
| 43 | MP0002184_abnormal_innervation | 1.55152724 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.54335427 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.53051079 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.52307749 |
| 47 | MP0003122_maternal_imprinting | 1.49883898 |
| 48 | MP0000955_abnormal_spinal_cord | 1.48318635 |
| 49 | MP0000778_abnormal_nervous_system | 1.44062334 |
| 50 | MP0001984_abnormal_olfaction | 1.41857237 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.41642272 |
| 52 | MP0004924_abnormal_behavior | 1.38822300 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.38822300 |
| 54 | MP0003879_abnormal_hair_cell | 1.38420978 |
| 55 | MP0003787_abnormal_imprinting | 1.34339608 |
| 56 | MP0005379_endocrine/exocrine_gland_phen | 1.33755473 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.32722216 |
| 58 | MP0003633_abnormal_nervous_system | 1.30653351 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.28531810 |
| 60 | * MP0002066_abnormal_motor_capabilities/c | 1.22178073 |
| 61 | MP0001756_abnormal_urination | 1.13382509 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.12110459 |
| 63 | MP0003634_abnormal_glial_cell | 1.11645707 |
| 64 | MP0002693_abnormal_pancreas_physiology | 1.09556650 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.09369467 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.08563857 |
| 67 | MP0005220_abnormal_exocrine_pancreas | 1.05347108 |
| 68 | * MP0001944_abnormal_pancreas_morphology | 1.04944766 |
| 69 | MP0003631_nervous_system_phenotype | 1.03977801 |
| 70 | MP0000639_abnormal_adrenal_gland | 1.02543883 |
| 71 | MP0003690_abnormal_glial_cell | 0.99392046 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 0.98833586 |
| 73 | * MP0010329_abnormal_lipoprotein_level | 0.97840830 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.97674377 |
| 75 | MP0001299_abnormal_eye_distance/ | 0.97293212 |
| 76 | MP0002152_abnormal_brain_morphology | 0.96804464 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 0.96028877 |
| 78 | MP0005332_abnormal_amino_acid | 0.95266771 |
| 79 | MP0002090_abnormal_vision | 0.95213073 |
| 80 | * MP0005645_abnormal_hypothalamus_physiol | 0.95108627 |
| 81 | MP0003075_altered_response_to | 0.94758091 |
| 82 | MP0000920_abnormal_myelination | 0.94305085 |
| 83 | * MP0002069_abnormal_eating/drinking_beha | 0.93789769 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.93640433 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 0.91675005 |
| 86 | MP0001529_abnormal_vocalization | 0.91612146 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.91303128 |
| 88 | MP0001905_abnormal_dopamine_level | 0.90876487 |
| 89 | MP0000678_abnormal_parathyroid_gland | 0.90714150 |
| 90 | MP0002234_abnormal_pharynx_morphology | 0.89377556 |
| 91 | MP0002229_neurodegeneration | 0.89250017 |
| 92 | * MP0005535_abnormal_body_temperature | 0.84953011 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.84511184 |
| 94 | MP0004085_abnormal_heartbeat | 0.83340377 |
| 95 | MP0000604_amyloidosis | 0.82977195 |
| 96 | MP0000751_myopathy | 0.80936490 |
| 97 | MP0004142_abnormal_muscle_tone | 0.79884381 |
| 98 | MP0004133_heterotaxia | 0.79730459 |
| 99 | MP0005365_abnormal_bile_salt | 0.79448011 |
| 100 | * MP0005448_abnormal_energy_balance | 0.79381663 |
| 101 | MP0003195_calcinosis | 0.78183981 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.77575423 |
| 103 | MP0001177_atelectasis | 0.77280237 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.76737996 |
| 105 | * MP0002078_abnormal_glucose_homeostasis | 0.76187952 |
| 106 | MP0004233_abnormal_muscle_weight | 0.75888904 |
| 107 | MP0003632_abnormal_nervous_system | 0.75677276 |
| 108 | MP0002928_abnormal_bile_duct | 0.74387058 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.74297835 |
| 110 | MP0000462_abnormal_digestive_system | 0.74197963 |
| 111 | MP0003868_abnormal_feces_composition | 0.73931834 |
| 112 | MP0004147_increased_porphyrin_level | 0.73563595 |
| 113 | MP0001188_hyperpigmentation | 0.73052402 |
| 114 | MP0002938_white_spotting | 0.71543095 |
| 115 | MP0005253_abnormal_eye_physiology | 0.69804480 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.68055013 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.65330022 |
| 118 | MP0005499_abnormal_olfactory_system | 0.65323867 |
| 119 | MP0005394_taste/olfaction_phenotype | 0.65323867 |
| 120 | * MP0003953_abnormal_hormone_level | 0.64450119 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.61766572 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.60157724 |
| 123 | MP0005187_abnormal_penis_morphology | 0.59922132 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.58756126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.01377728 |
| 2 | Myokymia (HP:0002411) | 5.27391259 |
| 3 | Visual hallucinations (HP:0002367) | 5.05968105 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.51156646 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.31699292 |
| 6 | Focal seizures (HP:0007359) | 4.30938290 |
| 7 | Megalencephaly (HP:0001355) | 4.12347173 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.03190216 |
| 9 | Hyperglycemia (HP:0003074) | 3.74732597 |
| 10 | Atonic seizures (HP:0010819) | 3.58297105 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.43548948 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.42571517 |
| 13 | Absence seizures (HP:0002121) | 3.38337998 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.31056100 |
| 15 | Papilledema (HP:0001085) | 3.29147500 |
| 16 | Depression (HP:0000716) | 3.29072231 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.24305294 |
| 18 | Action tremor (HP:0002345) | 3.22724499 |
| 19 | Double outlet right ventricle (HP:0001719) | 3.19882727 |
| 20 | Congenital malformation of the right heart (HP:0011723) | 3.19882727 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.11419304 |
| 22 | Febrile seizures (HP:0002373) | 3.10132940 |
| 23 | Anxiety (HP:0000739) | 3.09093206 |
| 24 | Enlarged penis (HP:0000040) | 3.05812449 |
| 25 | Dialeptic seizures (HP:0011146) | 3.04623919 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 3.00919368 |
| 27 | EEG with generalized epileptiform discharges (HP:0011198) | 3.00280252 |
| 28 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.00082115 |
| 29 | Hemiparesis (HP:0001269) | 2.97738833 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 2.93751591 |
| 31 | Hypsarrhythmia (HP:0002521) | 2.91231515 |
| 32 | Hypothermia (HP:0002045) | 2.90233277 |
| 33 | Agitation (HP:0000713) | 2.90171730 |
| 34 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.87089951 |
| 35 | Ankle clonus (HP:0011448) | 2.85131972 |
| 36 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.84780770 |
| 37 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.78478309 |
| 38 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.78478309 |
| 39 | Truncal ataxia (HP:0002078) | 2.70061487 |
| 40 | Late onset (HP:0003584) | 2.68952630 |
| 41 | Pheochromocytoma (HP:0002666) | 2.67793411 |
| 42 | Diplopia (HP:0000651) | 2.57642039 |
| 43 | Abnormality of binocular vision (HP:0011514) | 2.57642039 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.56059409 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.54051065 |
| 46 | Dysdiadochokinesis (HP:0002075) | 2.53742219 |
| 47 | Postural instability (HP:0002172) | 2.53357423 |
| 48 | Hyperthyroidism (HP:0000836) | 2.53291779 |
| 49 | Poor eye contact (HP:0000817) | 2.49498298 |
| 50 | Hypomagnesemia (HP:0002917) | 2.48417587 |
| 51 | Intestinal atresia (HP:0011100) | 2.48111476 |
| 52 | Increased CSF protein (HP:0002922) | 2.47979435 |
| 53 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.42387252 |
| 54 | Symptomatic seizures (HP:0011145) | 2.37004435 |
| 55 | Muscular hypotonia of the trunk (HP:0008936) | 2.36029602 |
| 56 | Akinesia (HP:0002304) | 2.34163505 |
| 57 | Aplasia involving bones of the extremities (HP:0009825) | 2.32352226 |
| 58 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.32352226 |
| 59 | Aplasia of the phalanges of the hand (HP:0009802) | 2.32352226 |
| 60 | Hemiplegia (HP:0002301) | 2.29775147 |
| 61 | Dysmetria (HP:0001310) | 2.29248397 |
| 62 | Hyperphosphatemia (HP:0002905) | 2.28851443 |
| 63 | Impaired smooth pursuit (HP:0007772) | 2.28161428 |
| 64 | Abnormal social behavior (HP:0012433) | 2.25056462 |
| 65 | Impaired social interactions (HP:0000735) | 2.25056462 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.24749513 |
| 67 | Amblyopia (HP:0000646) | 2.22277198 |
| 68 | Broad-based gait (HP:0002136) | 2.22134513 |
| 69 | Hyperventilation (HP:0002883) | 2.20585077 |
| 70 | Drooling (HP:0002307) | 2.20095840 |
| 71 | Excessive salivation (HP:0003781) | 2.20095840 |
| 72 | Polydipsia (HP:0001959) | 2.19398342 |
| 73 | Abnormal drinking behavior (HP:0030082) | 2.19398342 |
| 74 | Bradykinesia (HP:0002067) | 2.18259004 |
| 75 | Diminished movement (HP:0002374) | 2.15528579 |
| 76 | Ketosis (HP:0001946) | 2.15145508 |
| 77 | Torticollis (HP:0000473) | 2.14891716 |
| 78 | Large for gestational age (HP:0001520) | 2.14746912 |
| 79 | Testicular neoplasm (HP:0010788) | 2.13607458 |
| 80 | Poor suck (HP:0002033) | 2.08164764 |
| 81 | Macroorchidism (HP:0000053) | 2.06891745 |
| 82 | Abnormality of vitamin B metabolism (HP:0004340) | 2.06663150 |
| 83 | Ketoacidosis (HP:0001993) | 2.06531599 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.05956268 |
| 85 | Fetal akinesia sequence (HP:0001989) | 2.05133441 |
| 86 | Decreased circulating renin level (HP:0003351) | 2.05127195 |
| 87 | Ventricular fibrillation (HP:0001663) | 2.05054233 |
| 88 | Menstrual irregularities (HP:0000858) | 2.04802174 |
| 89 | Focal dystonia (HP:0004373) | 2.04203871 |
| 90 | Intention tremor (HP:0002080) | 2.00689609 |
| 91 | Increased circulating renin level (HP:0000848) | 1.99584032 |
| 92 | Genetic anticipation (HP:0003743) | 1.98803147 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 1.98159734 |
| 94 | Abnormality of vitamin metabolism (HP:0100508) | 1.97206247 |
| 95 | Sleep apnea (HP:0010535) | 1.96856177 |
| 96 | Blue irides (HP:0000635) | 1.94423083 |
| 97 | Abnormality of magnesium homeostasis (HP:0004921) | 1.93715518 |
| 98 | Hypercortisolism (HP:0001578) | 1.93008933 |
| 99 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92324025 |
| 100 | Resting tremor (HP:0002322) | 1.91520715 |
| 101 | Prolonged QT interval (HP:0001657) | 1.90191210 |
| 102 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.89996267 |
| 103 | Spastic gait (HP:0002064) | 1.89046133 |
| 104 | Aqueductal stenosis (HP:0002410) | 1.88360220 |
| 105 | Ankyloglossia (HP:0010296) | 1.88327170 |
| 106 | Stereotypic behavior (HP:0000733) | 1.87803563 |
| 107 | Status epilepticus (HP:0002133) | 1.87135850 |
| 108 | Insomnia (HP:0100785) | 1.86711954 |
| 109 | Hypokinesia (HP:0002375) | 1.86513592 |
| 110 | Spinal canal stenosis (HP:0003416) | 1.85359770 |
| 111 | Retinal atrophy (HP:0001105) | 1.82555666 |
| 112 | Medial flaring of the eyebrow (HP:0010747) | 1.81191638 |
| 113 | Restlessness (HP:0000711) | 1.80721691 |
| 114 | Mutism (HP:0002300) | 1.79751964 |
| 115 | Bundle branch block (HP:0011710) | 1.79679748 |
| 116 | Psychosis (HP:0000709) | 1.79642800 |
| 117 | Urethral obstruction (HP:0000796) | 1.79343497 |
| 118 | Polyphagia (HP:0002591) | 1.79243416 |
| 119 | Neoplasm of the heart (HP:0100544) | 1.79154398 |
| 120 | Urinary urgency (HP:0000012) | 1.78916709 |
| 121 | Limb dystonia (HP:0002451) | 1.77948253 |
| 122 | Progressive inability to walk (HP:0002505) | 1.77902876 |
| 123 | Bronchomalacia (HP:0002780) | 1.77492485 |
| 124 | Gait ataxia (HP:0002066) | 1.76621702 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.75169787 |
| 126 | Hyperparathyroidism (HP:0000843) | 1.74985035 |
| 127 | Postural tremor (HP:0002174) | 1.74724878 |
| 128 | Lower limb muscle weakness (HP:0007340) | 1.74276193 |
| 129 | Syncope (HP:0001279) | 1.74254555 |
| 130 | Scanning speech (HP:0002168) | 1.73839250 |
| 131 | Craniofacial dystonia (HP:0012179) | 1.73699652 |
| 132 | Abnormal EKG (HP:0003115) | 1.73216009 |
| 133 | Type II lissencephaly (HP:0007260) | 1.72537458 |
| 134 | Generalized myoclonic seizures (HP:0002123) | 1.72337946 |
| 135 | Gait imbalance (HP:0002141) | 1.71289686 |
| 136 | Progressive macrocephaly (HP:0004481) | 1.71136356 |
| 137 | Vascular calcification (HP:0004934) | 1.70910788 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.70583949 |
| 139 | Clonus (HP:0002169) | 1.69882010 |
| 140 | Methylmalonic acidemia (HP:0002912) | 1.69691810 |
| 141 | Impaired vibratory sensation (HP:0002495) | 1.67860054 |
| 142 | Retinal dysplasia (HP:0007973) | 1.67831526 |
| 143 | Failure to thrive in infancy (HP:0001531) | 1.67644093 |
| 144 | Tetraplegia (HP:0002445) | 1.66583650 |
| 145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.66223355 |
| 146 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.66223355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.50363268 |
| 2 | NTRK3 | 4.38320315 |
| 3 | PRKD3 | 3.77577366 |
| 4 | FGFR2 | 3.31346321 |
| 5 | MAP3K9 | 3.23437251 |
| 6 | MAP3K4 | 2.49609575 |
| 7 | MINK1 | 2.31741293 |
| 8 | NTRK2 | 2.29067108 |
| 9 | MARK1 | 2.27385237 |
| 10 | NTRK1 | 2.14632399 |
| 11 | KSR2 | 2.13651783 |
| 12 | MAP2K7 | 2.04141425 |
| 13 | DAPK2 | 2.02806472 |
| 14 | MAP3K2 | 1.97652844 |
| 15 | PAK6 | 1.93712343 |
| 16 | INSRR | 1.90457307 |
| 17 | CAMKK1 | 1.82675570 |
| 18 | FGFR3 | 1.78104469 |
| 19 | LMTK2 | 1.69213765 |
| 20 | RIPK4 | 1.61263262 |
| 21 | CDK5 | 1.52764178 |
| 22 | UHMK1 | 1.49089671 |
| 23 | PHKG1 | 1.46773663 |
| 24 | PHKG2 | 1.46773663 |
| 25 | KSR1 | 1.45341991 |
| 26 | MAP2K6 | 1.41460827 |
| 27 | MAP2K4 | 1.39621444 |
| 28 | ARAF | 1.39156325 |
| 29 | MAP4K2 | 1.38707184 |
| 30 | WNK3 | 1.38318792 |
| 31 | CAMKK2 | 1.36705712 |
| 32 | MAPK15 | 1.32325486 |
| 33 | GRK1 | 1.32136534 |
| 34 | GRK5 | 1.24083182 |
| 35 | PRKCH | 1.21851192 |
| 36 | PLK2 | 1.21371273 |
| 37 | STK38 | 1.20158655 |
| 38 | PAK3 | 1.19417052 |
| 39 | PRKCG | 1.18177761 |
| 40 | TNIK | 1.17325268 |
| 41 | CASK | 1.12879218 |
| 42 | DAPK1 | 1.12143142 |
| 43 | SGK494 | 1.11494700 |
| 44 | SGK223 | 1.11494700 |
| 45 | MAP3K12 | 1.08639077 |
| 46 | MAPK13 | 1.07921395 |
| 47 | PINK1 | 1.02522069 |
| 48 | SIK2 | 1.01596643 |
| 49 | MAP3K13 | 0.98970323 |
| 50 | MAP3K1 | 0.98704766 |
| 51 | SGK2 | 0.98372184 |
| 52 | CSNK1G1 | 0.96220303 |
| 53 | TYRO3 | 0.93767330 |
| 54 | PNCK | 0.91893805 |
| 55 | CAMK2A | 0.89077446 |
| 56 | BMPR2 | 0.87383535 |
| 57 | RET | 0.85916770 |
| 58 | CDC42BPA | 0.85449411 |
| 59 | PRPF4B | 0.85338496 |
| 60 | HIPK2 | 0.84261805 |
| 61 | FES | 0.84175513 |
| 62 | CSNK1G3 | 0.83823571 |
| 63 | ADRBK2 | 0.83058603 |
| 64 | WNK4 | 0.81186186 |
| 65 | SGK3 | 0.80960003 |
| 66 | TRPM7 | 0.78290098 |
| 67 | DYRK1A | 0.77655570 |
| 68 | STK39 | 0.77142867 |
| 69 | SCYL2 | 0.77127391 |
| 70 | CAMK2B | 0.75668733 |
| 71 | AKT3 | 0.74269724 |
| 72 | OXSR1 | 0.73466613 |
| 73 | SGK1 | 0.71158348 |
| 74 | CDK14 | 0.70241148 |
| 75 | PRKCE | 0.70022195 |
| 76 | CAMK1 | 0.69378992 |
| 77 | CDK18 | 0.68588116 |
| 78 | PDGFRA | 0.67699394 |
| 79 | STK24 | 0.67197358 |
| 80 | CDK15 | 0.67080469 |
| 81 | MST4 | 0.65227769 |
| 82 | FER | 0.64792586 |
| 83 | BMPR1B | 0.64056738 |
| 84 | FRK | 0.63780301 |
| 85 | TRIB3 | 0.62651185 |
| 86 | PRKD2 | 0.62159118 |
| 87 | CDK19 | 0.62081320 |
| 88 | STK38L | 0.62004305 |
| 89 | PRKAA1 | 0.61859655 |
| 90 | STK11 | 0.61237275 |
| 91 | TNK2 | 0.61062517 |
| 92 | PTK2B | 0.60226119 |
| 93 | NEK6 | 0.60092556 |
| 94 | TAOK1 | 0.59994298 |
| 95 | RAF1 | 0.59745492 |
| 96 | CAMK2D | 0.59719623 |
| 97 | CDK11A | 0.56560331 |
| 98 | PRKG1 | 0.56480291 |
| 99 | EPHA3 | 0.56004770 |
| 100 | PASK | 0.54971948 |
| 101 | LIMK1 | 0.54788451 |
| 102 | NLK | 0.54545994 |
| 103 | ALK | 0.54198714 |
| 104 | PDPK1 | 0.52988716 |
| 105 | ROCK2 | 0.52162769 |
| 106 | MARK2 | 0.51928077 |
| 107 | WNK1 | 0.50963409 |
| 108 | NME1 | 0.50545107 |
| 109 | RPS6KA3 | 0.49892613 |
| 110 | BRSK1 | 0.49268951 |
| 111 | PDK1 | 0.48772698 |
| 112 | DDR2 | 0.47418903 |
| 113 | MAPK10 | 0.47408735 |
| 114 | CSNK1A1 | 0.47101123 |
| 115 | ERBB3 | 0.46173642 |
| 116 | MAP2K1 | 0.45713502 |
| 117 | CSNK1D | 0.45542299 |
| 118 | STK3 | 0.45145227 |
| 119 | ROCK1 | 0.45114400 |
| 120 | RIPK1 | 0.42959670 |
| 121 | PRKACA | 0.42663849 |
| 122 | PRKCZ | 0.42525124 |
| 123 | CSNK1G2 | 0.41958812 |
| 124 | CSNK1E | 0.41885217 |
| 125 | LATS2 | 0.41706329 |
| 126 | CAMK1G | 0.40704667 |
| 127 | PRKCA | 0.38784357 |
| 128 | PTK2 | 0.37846755 |
| 129 | BRAF | 0.37497380 |
| 130 | YES1 | 0.37437519 |
| 131 | CAMK2G | 0.37289627 |
| 132 | CSNK1A1L | 0.35877936 |
| 133 | MKNK2 | 0.35863404 |
| 134 | FYN | 0.33957053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.90933968 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.87712028 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.82320949 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57022579 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50845539 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46984381 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.44354027 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.39656012 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.33037925 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.30297893 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.29581041 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.20897485 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11722124 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07472256 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.00440827 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.96249991 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.93640117 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88030666 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87281610 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82259592 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.79505589 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.75643890 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.71959252 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70593709 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.59347250 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57444243 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55536136 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55423689 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.53673222 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.44800581 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38883319 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.37472937 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37048349 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35771756 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32360421 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32269071 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.32053034 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28082424 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26103747 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26018998 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.22721746 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16720095 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15473813 |
| 44 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.09812304 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06985177 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06336941 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05663471 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05543051 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 1.04976167 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03738297 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02051877 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98183928 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.96402478 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94223945 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93919471 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93578854 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.93030958 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89173637 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88241998 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83848756 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83103282 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82793054 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81355079 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80146944 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79887557 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79693204 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.77211671 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76954429 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76709542 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74381806 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.73992565 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72860401 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71683771 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69958202 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69500109 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68209313 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.63773089 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.62412059 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62049449 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61281489 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61256375 |
| 82 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61031071 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60664000 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60606605 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60322549 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58932725 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56822403 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56515120 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.56199536 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56147863 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55471675 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.55257510 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.54506003 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54211547 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52941123 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51601642 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.51316669 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50581485 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49940092 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49738875 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48407064 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47883393 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47779797 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46773809 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44802616 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44739113 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43834250 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43162894 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42864110 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42862769 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42832622 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42770149 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.41034026 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40561214 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40524059 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.39763364 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38713667 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38677029 |
| 119 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38348813 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36955560 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35989884 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35326094 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34425429 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34264156 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33176672 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31845722 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31532391 |
| 128 | Insulin resistance_Homo sapiens_hsa04931 | 0.29801642 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29271362 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28714301 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.28279032 |
| 132 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.26216256 |
| 133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26178646 |

